FDA Releases Slew of Product-Specific Draft Guidances

Generic Line
A A
The FDA published new product-specific draft guidances for establishing bioequivalence in 20 drugs and combinations. The agency also revised draft guidances for 12 more substances.

To View This Article:

Login

Subscribe To Generic Line